Pharmatech, Inc. Announces Research Collaboration under Phase II NCI/SBIR Grant with Weill Cornell Medical College
September 23, 2013 - Pharmatech and Weill Cornell Medical College have agreed to evaluate, rapid approach to identifying and enrolling patients
September 18, 2013 - Pharmatech Inc. introduced their communications and trial management technology platform: TrialPlus+, on August 1st.
August 7, 2013 - Enrollment and precision medicine present two major challenges in completing oncology clinical trials in a timely and cost effective way.
March 6, 2013 - Pharmatech, Inc. Promoted Judy Romano to Director of Clinical Operations.
November 5, 2012 - Pharmatech Oncology is on-target for setting a record growth year for 2012.
October 22, 2012 - Pharmatech Oncology is progressing toward commercializing its proprietary project document management system for creating greater efficiency in clinical trials.
August 25, 2012 - Pharmatech Oncology is pleased to announce that Wendy Garza, MBA has joined the company as its Controller, effective August 25th.
PHARMATECH ONCOLOGY IS HOSTING A SITE FEASIBILITY AND SITE SELECTION WEBINAR ON WEDNESDAY, AUGUST 22ND
August 13, 2012 - Pharmatech Oncology, Inc. is hosting a Site Feasibility and Site Selection Webinar on Wednesday, August 22nd at 12PM MST.
August 9, 2012 - Pharmatech Oncology announces the award of its phase 2 Small Business Innovative Research (SBIR) project, entitled A Patient Centered Approach to Enrolling Rare Cancer Patients in Clinical Trials, to be funded through the National Cancer Institute (NCI).
May 3, 2012 - Pharmatech Oncology, a Denver based CRO and SMO is collaborating with PCM TRIALS to provide cancer patients the benefit of receiving clinical study visits in the comfort of their homes.
May 1, 2012 - Pharmatech Oncology, Inc. announced today a change in its chief executive officer.
October 19, 2011 - Pharmatech Oncology announces completion of a phase I Small Business Innovative Research (SBIR) grant project, funded by the National Cancer Institute (NCI).
October 11, 2010 - Pharmatech Oncology announces an abstract supported by the company has been accepted for presentation during the 52nd annual American Society of Hematology (ASH) meeting in Orlando, FL, December 4-7, 2010.
July 6, 2010 - Tamir Biotechnology, Inc today announced that it has selected Pharmatech Oncology, Inc. as the Clinical Research Organization to run its upcoming Phase II trial of RANPIRNASE (ONCONASE® in combination with platinum doublet chemotherapy for patients with advanced or metastatic non-squamous, non-small cell lung cancer (NSCLC).
June 25, 2010 - Eric Lynam, VP of Business Development for Pharmatech Oncology, led a session at the 46th Annual Drug Information Association Meeting earlier this month. The session was well-attended and generated a great discussion.
June 10, 2010 - On Wednesday June 16, Pharmatech Oncology will chair a session at the 46th Annual DIA Meeting to discuss patient-focused clinical research systems in the age of personalized cancer medicine. Speakers will include Jeffrey Vacirca MD, Director of Clinical Research at North Shore Hematology/Oncology Associates in East Setauket, NY and Matt Baker, President and CEO of Compass IRB in Mesa, AZ.
May 17, 2010 - Pharmatech Oncology announces that abstracts for two studies supported by the company have been accepted for presentations during the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, IL, June 4-8, 2010.
April 23, 2009 - Pharmatech Oncology, Inc., a Research Management Organization (RMO), has been selected as one of the presenting companies at the Company Showcase during BIOZONA 2009 – Arizona’s Annual Bioscience Industry Conference at the Sheraton Phoenix Downtown on April 7th in Phoenix, Arizona.
April 7, 2009 - Pharmatech Oncology, Inc., a Research Management Organization (RMO) headquartered in Denver, Colorado, announces the launch of their Data Management business unit to the bioscience and pharmaceutical industries.
March 18, 2009 - Pharmatech Oncology has been selected by the Fitzsimons Redevelopment Authority to be a preferred vendor to the Colorado Science + Technology Park at Fitzsimons.
December 30, 2008 - Pharmatech, Inc. announces the launch of a new campaign, Pharmatech 2.0, to highlight the company’s focus in oncology, along with other key company developments that will take place in early January 2009.
September 30, 2008 - Matthew B. Wiener, PharmD, Chief Executive Officer of Pharmatech, Inc., was recently awarded the Outstanding Cancer Leadership Award from the Colorado Cancer Coalition.
July 24, 2008 - Pharmatech, Inc., a Research Management Organization (RMO), has contracted with five leading pharmaceutical companies to provide research and site management services for their clinical trials using the Just-in-Time (JIT) enrollment strategy.
Pharmatech Teams up with Systems Medicine LLC and The Sarcoma Foundation of America for a Phase II Myxoid Liposarcoma Trial
March 3, 2008 - Pharmatech, Inc., a Research Management Organization (RMO), has contracted with Systems Medicine LLC (SML), a subsidiary of Seattle-based Cell Therapeutics, Inc. (CTI), to provide research and site management services for their phase II open-label clinical study for patients with myxoid liposarcoma with a (12;16) translocation.
December 4, 2007 - Pharmatech, Inc., a Research Management Organization (RMO), will be presenting preliminary data from two clinical trials evaluating combination therapy to treat patients with Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin’s Lymphoma (NHL) at the American Society of Hematology’s Annual Meeting, to be held December 8-11 in Atlanta, Georgia.
November 7, 2007 - Pharmatech, Inc. is pleased to announce that one of their Project Managers, Heike Newman, MS, MBA, received the Special Recognition Award from the Society of Clinical Research Associates (SoCRA) for her collaboration on an abstract and poster presentation.
July 2, 2007 - OmniComm Systems, Inc. (OTC Bulletin Board: OMCM), one of the fastest growing companies in the EDC marketplace, today announced that it will partner with Pharmatech, Inc., a Research Management Organization (RMO), to build a patient registry database that will improve patient accrual in clinical trials.
February 16, 2006 - Pharmatech, Inc. is a Research Management Organization (RMO) dedicated to the highest quality of clinical research, while protecting patient care and patient safety. Pharmatech combines the services of Clinical Research Organizations (CROs) with a refined research network of over 1500 investigators, caring for ½ million cancer patients in oncology and urology care.
May 4, 2005 - Pharmatech, a Research Management Organization (RMO) within the oncology field of the pharmaceutical research industry, is pleased to announce the hiring of two new executives to the management team. Anders Malm is the new President and Dale Coykendall is the new Chief Financial Officer (CFO).
July 25, 2003 - Pharmatech, Inc., a Research Management Organization (RMO), has presented preliminary data from a clinical trial testing the combination of Nipent® and Rituxan® to treat patients with Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin’s Lymphoma (NHL).
February 14, 2003 - Pharmatech, the only Research Management Organization (RMO) in the pharmaceutical research industry, announces a new site-centric model. The purpose of developing this approach is to better provide customer service in a more personalized manner to Network members involved with Pharmatech.